Allena Pharmaceuticals, Inc. announced the appointment of Andrew A. F. Hack, M.D., Ph.D., to its Board of Directors. Dr. Hack will serve as Chair of the Audit Committee. Dr. Hack has served as Chief Financial Officer of Editas Medicine since 2015. Prior to joining Editas, Dr. Hack was a portfolio manager at Millennium Management LLC, where he ran a healthcare fund focused on biotechnology, pharmaceutical and medical device companies. Before joining Millennium, Dr. Hack was a healthcare analyst at HealthCor Management and Carlyle-Blue Wave Partners. He also served as principal of the MPM BioEquities Fund. Dr. Hack began his investment career covering the biotechnology sector at Bank of America and Rodman & Renshaw, and before that, co-founded Reify Corporation, a life science tools and drug discovery company. Dr. Hack currently serves on the board of Mersana Therapeutics. He received a B.A. in Biology with special honors from the University of Chicago, where he also received his M.D. and Ph.D.